Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 26 Breast Neoplasms 26 Lung Neoplasms 24 Colonic Neoplasms 18 Head and Neck Neoplasms 16 Rectal Neoplasms 14 Prostatic Neoplasms 11 Sarcoma 10 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Neoplasms 7 Mouth Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Ovarian Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Neuroblastoma 5 Liver Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4

Interventions

Vinblastine 1 Methotrexate 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Survival Without Progression × Celecoxib × Clear all

NCT01285817 2023-03-13

SFCE METRO 01

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Survival Without Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡